Pharmacological protection of hearing loss in the mouse model of endolymphatic hydrops

Laryngoscope

Volumn 120, Issue 8, 2010, Pages 1637-1645

  Melki, Sami J ^a   Heddon, Chris M ^a   Frankel, Jonathan K ^a   Levitt, Alex H ^a   Momin, Suhael R ^a   Alagramam, Kumar N ^a   Megerian, Cliff A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Dimethylsulfoxide; Endolymphatic hydrops; Glutamate; Hearing loss; Mouse; Riluzole

Indexed keywords

DIMETHYL SULFOXIDE; RILUZOLE; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COCHLEA DUCT; CONTROLLED STUDY; EAR PROTECTION; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; HEARING ACUITY; HEARING LOSS; MALE; MENIERE DISEASE; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RATING SCALE; ANIMAL; DISEASE MODEL; PATHOPHYSIOLOGY;

ANIMALS; DIMETHYL SULFOXIDE; DISEASE MODELS, ANIMAL; ENDOLYMPHATIC HYDROPS; HEARING LOSS; MICE; NEUROPROTECTIVE AGENTS; REACTIVE OXYGEN SPECIES; RILUZOLE;

EID: 77955905636     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21018     Document Type: Article

References (34)

1. Hallpike C. Observations on the pathology of Meniere's syndrome. Proc R Soc Med 1938;31:55-73.
2. Kimura R, Schuknecht H. Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac. Pract Otolaryngol 1965;27:343-354.
3. Megerian CA. Diameter of the cochlear nerve in endolymphatic hydrops: implications for the etiology of hearing loss in Meniere's disease. Laryngoscope 2005;115:1525-1535.
4. Anne S, Kisley LB, Tajuddin ST, Leahy P, Alagramam KN, Megerian CA. Molecular changes associated with the endolymphatic hydrops model. Otol Neurotol 2007;28:834-841.
5. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994;330:613-622.
6. Nordang L, Cestreicher E, Arnold W, Anniko M. Glutamate is the afferent neurotransmitter in the human cochlea. Acta Otolaryngol 2000;120:359-362.
7. Ruel J, Wang J, Rebillard G, et al. Physiology, pharmacology and plasticity at the inner hair cell synaptic complex. Hear Res 2007;227:19-27.
8. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003;4:552-565.
9. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424.
10. Ruel J, Wang J, Pujol R, Hameg A, Dib M, Puel JL. Neuroprotective effect of riluzole in acute noise-induced hearing loss. Neuroreport 2005;16:1087-1090.
11. Hugon J. Riluzole and ALS therapy. Wien Med Wochenschr 1996;146:185-187.
12. Wang J, Dib M, Lenoir M, et al. Riluzole rescues cochlear sensory cells from acoustic trauma in the guinea-pig. Neuroscience 2002;111:635-648.
13. Lu C, Mattson MP. Dimethyl sulfoxide suppresses NMDA- and AMPA-induced ion currents and calcium influx and protects against excitotoxic death in hippocampal neurons. Exp Neurol 2001;170:180-185.
14. Zhang XQ, Eyzaguirre C. Effects of hypoxia induced by Na2S2O4 on intracellular calcium and resting potential of mouse glomus cells. Brain Res 1999;818:118-126.
15. Salim AS. Oxygen-derived free radical scavengers protect patients against the complications of erosive gastritis. Intensive Care Med 1992;18:61-62.
16. Lorenz-Depiereux B, Guido VE, Johnson KR, et al. New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice. Mamm Genome 2004;15:151-161.
17. Megerian CA, Semaan MT, Aftab S, et al. A mouse model with postnatal endolymphatic hydrops and hearing loss. Hear Res 2008;237:90-105.
18. Fishman G, Miller-Hansen D, Jacobsen C, Singhal VK, Alon US. Hearing impairment in familial X-linked hypophosphatemic rickets. Eur J Pediatr 2004;163:622-623.
19. Momin SR, Melki SJ, Alagramam KN, Megerian CA. Spiral ganglion loss outpaces inner hair cell loss in endolymphatic hydrops. Laryngoscope 2010;120:159-165.
20. Boatright JH, Moring AG, McElroy C, et al. Tool from ancient pharmacopoeia prevents vision loss. Mol Vis 2006;12:1706-1714.
21. Zheng QY, Yu H, Washington JL III, et al. A new spontaneous mutation in the mouse protocadherin 15 gene. Hear Res 2006;219:110-120.
22. Yagi M, Kanzaki S, Kawamoto K, et al. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 2000;1:315-325.
23. Noben-Trauth K, Zheng QY, Johnson KR. Association of cadherin 23 with polygenic inheritance and genetic modification of sensorineural hearing loss. Nat Genet 2003;35:21-23.
24. Sajjadi H, Paparella MM. Meniere's disease. Lancet 2008;372:406-414.
25. Ikeda Y, Long DM. Comparative effects of direct and indirect hydroxyl radical scavengers on traumatic brain oedema. Acta Neurochir Suppl (Wien) 1990;51:74-76.
26. Wu WJ, Sha SH, McLaren JD, Kawamoto K, Raphael Y, Schacht J. Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Hear Res 2001;158:165-178.
27. Adams JC. Clinical implications of inflammatory cytokines in the cochlea: a technical note. Otol Neurotol 2002;23:316-322.
28. Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005;26:74-81.
29. Shinomori YK, Kimura RS, Adams J. Changes in immunostaining for Na+, K+, 2Cl-cotransporter 1, taurine, and c-Jun N-terminal kinase in experimentally induced endolymphatic hydrops. ARO Abstract 2001;24:134.
30. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305-311.
31. Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 2007;9(suppl 1):S1.
32. Mikulec AA, Plontke SK, Hartsock JJ, Salt AN. Entry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs: implications for local drug delivery in humans. Otol Neurotol 2009;30:131-138.
33. Zehnder AF, Kristiansen AG, Adams JC, Kujawa SG, Merchant SN, McKenna MJ. Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss. Laryngoscope 2006;116:201-206.
34. Katoh-Semba R, Asano T, Ueda H, et al. Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J 2002;16:1328-1330.